Nanomedicine Market has witnessed continuous growth within the past few years and is projected to grow even more throughout the forecast period (2020 2027). The analysis presents a whole assessment of the market and contains Future trends, Current Growth Factors, attentive opinions, facts, historical information, and statistically supported and trade valid market information.

The report, titled Global Nanomedicine Market defines and briefs readers about its products, applications, and specifications. The research lists key companies operating in the global market and also highlights the key changing trends adopted by the companies to maintain their dominance. By using SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and threats of key companies are all mentioned in the report. All leading players in this global market are profiled with details such as product types, business overview, sales, manufacturing base, competitors, applications, and specifications.

You Can Request A Demo Version of Report Before Buying (Higher Preference For Corporate Email ID User): https://www.worldwidemarketreports.com/sample/205987

GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A of the major organizations dominating the global market.(*Note: Other Players Can be Added per Request)

1. Industry outlookThis is where youll find the current state of the Nanomedicine industry overall and where its headed. Relevant industry metrics like size, trends, life cycle, and projected growth included here. This report comes prepared with the data to back up your business idea. On a regional basis, the Global Nanomedicine market has been segmented into Asia-Pacific, North America, Europe, Latin America, and the Middle East and Africa.

2. Target marketThis target market section of study includes the following:

User persona and characteristics: It includes demographics such as age, income, and location. It lets you know what their interests and buying habits are, as well as explain the best position to meet their needs.

Market size: How big is the potential Nanomedicine market for your business? It brings to light the consumption in the Nanomedicine industry by the type and application.

3. Competitive analysisDiscover your competitors. The report lets you know what youre up against, but it also lets you spot the competitions weaknesses. Are there customers that are underserved? What can you offer that similar businesses arent offering? The competitive analysis contains the following components:

Direct competitors: What other companies are offering similar products and services? Which companies are your true competitors?

Competitor strengths and weaknesses: What is your competition good at? Where do they fall behind? Get insights to spot opportunities to excel where others are falling short.

Barriers to entry: What are the potential pitfalls of entering the Nanomedicine market? Whats the cost of entry? Is it prohibitively high, or easy to enter?

The window of opportunity:Does your entry into the Nanomedicine industry rely on time-sensitive technology? Do you need to enter early to take advantage of an emerging market?

4. ProjectionsLikewise, We offered thoughtful, not hockey-stick forecasting.

Market share:We have given the consumption behavior of users. When you know how much can your future customers spend, then only youll understand how much of the Nanomedicine industry you have a chance to grab, and here we came up with real stats and numbers.

Impact Analysis of COVID-19:The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into account the political, economic, social, and technological parameters.

Finally, It is one report that hasnt shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of the Nanomedicine Industry, per application. Most noteworthy, this market analysis will help you find market blind spots.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Contact Us:

Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: [emailprotected]

Link:
Nanomedicine Market: Opportunities After COVID 19 That Will Help to Increase Revenue GE Healthcare, Johnson & Johnson, Mallinckrodt plc - Market...

February 6, 2017 (a) MMP-2 represented by little scissors is an enzyme that cleaves the extracellular matrix and allows cancer to metastasize to other tissues. (b) The MRI signal is turned "ON" when the linker between the two magnetic materials is cleaved by MMP-2. (c) MRI image of a mouse cancer model, showing strong MRI signals (orange color) appearing only in the cancerous region. Credit: IBS

A research team led by CHEON Jinwoo at the Center for Nanomedicine, within the Institute for Basic Science (IBS), developed the Nano MRI Lamp: A new technology platform that tunes the magnetic resonance imaging (MRI) signals "ON" only in the presence of the targeted disease. Published in Nature Materials, this study can overcome the limitations of existing MRI contrast agents.

MRI is an increasingly popular non-invasive technique for diagnosis and, importantly, does not use harmful radiation. Some tissues show a natural contrast on MRI, but for some specific types of imaging, patients are administered a MRI contrast agent to enhance the difference between the target area and the rest of the body. "Typical MRI contrast agents, like gadolinium, are injected in an "ON" state and distributed across the whole biological system with relatively large background signal," explains Director Cheon. "We found a new principle to switch the MRI contrast agent "ON" only in the location of the target." IBS scientists discovered how to switch the signal ON/OFF by using the Nano MRI Lamp.

The Nano MRI Lamp technology consists of two magnetic materials: A quencher (magnetic nanoparticle) and an enhancer (MRI contrast agent). The switch is due to the distance between the two. When the two materials are at a critical distance, farther than 7 nanometers (nm), the MRI signal is "ON", whereas when they are placed closer than 7 nm, the MRI signal is "OFF". The researchers named this phenomenon Magnetic REsonance Tuning (MRET), which is analogous to the powerful optical sensing technique called Fluorescence Resonance Energy Transfer (FRET).

The video will load shortly

The researchers tested the Nano MRI Lamp for cancer diagnosis. They detected the presence of an enzyme that can induce tumor metastasis, MMP-2 (matrix metalloproteinase-2) in mice with cancer. They connected the two magnetic materials with a linker that is naturally cleaved by MMP-2. Since the linker keeps the two materials close to each other, the MRI signal was "OFF". However, in the presence of the cancer, the linker is cleaved by MMP-2, which cause the two materials to be separated and the MRI signal switched "ON". Therefore, the MRI signal indicated the location of MMP-2, and the tumor. The scientists also found that the brightness of the MRI signal correlates with the concentration of MMP-2 in the cancerous tissue.

Most importantly, the Nano MRI Lamp remains switched off until it meets a biomarker associated with a specific disease, allowing higher sensitivity. "The current contrast agent is like using a flashlight during a sunny day: Its effect is limited. Instead, this new technology is like using a flash light at night and therefore more useful," explains Cheon.

Beyond cancer diagnosis, the Nano MRI Lamp can, in principle, be applied to investigate a variety of biological events, such as enzymolysis, pH variation, protein-protein interactions, etc. IBS scientists expect that it would be useful for both in vitro and in vivo diagnostics.

"Although we still have a long way to go, we established the principle and believe that the MRET and Nano MRI Lamp can serve as a novel sensing principle to augment the exploration of a wide range of biological systems," concludes Cheon. The research group is now working on developing safer and smarter multitasking contrast agents, which can simultaneously record and interpret multiple biological targets, and eventually allow a better understanding of biological processes and accurate diagnosis of diseases.

Explore further: Better contrast agents based on nanoparticles

More information: Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets, Nature Materials, nature.com/articles/doi:10.1038/nmat4846

Scientists at the University of Basel have developed nanoparticles which can serve as efficient contrast agents for magnetic resonance imaging. This new type of nanoparticles produce around ten times more contrast than the ...

(PhysOrg.com) -- Accurate visualization of living systems is key to the correct diagnosis and effective treatment of many diseases, as well as an improved understanding of biological processes. Magnetic resonance imaging ...

(Phys.org)A new type of nanoparticle-based MRI contrast agent demonstrates selectivity for tumor cells over non-cancerous cells, can detect hypoxia, and is sensitive enough allow for the detection of difficult-to-find ...

Ordinary sugar could become a contrast agent of the future for use in magnetic resonance tomography examinations of tumours. Malignant tumours show higher sugar consumption than surrounding tissue.

Nanoscale, inorganic fluorescent imaging agents such as quantum dots have become an important tool for researchers studying key biomolecules involved in cancer. At the same time, magnetic iron oxide nanoparticles are proving ...

Scientists from the Helmholtz Zentrum Mnchen and the Technische Universitt Mnchen have succeeded in a breakthrough for the further development of contrast agents and consequently improved diagnostics with imaging using ...

(Phys.org)In an effort to curb the adverse environmental impacts of paper production, researchers in a new study have developed a light-printable paperpaper that can be printed with UV light, erased by heating to 120 ...

Scientists used one of the world's most powerful electron microscopes to map the precise location and chemical type of 23,000 atoms in an extremely small particle made of iron and platinum.

Researchers at The University of Manchester have developed a method of producing water-based and inkjet printable 2-D material inks, which could bring 2-D crystal heterostructures from the lab into real-world products.

Rice University researchers have synthesized a new and greatly improved generation of contrast agents for tagging and real-time tracking of stem cells in the body.

Imaging very small materials takes not only great skill on the part of the microscopist, but also great instruments and techniques. For a refined microscopic look at biological materials, the challenges include getting an ...

Hold on, there, graphene. You might think you're the most interesting new nanomaterial of the century, but boron might already have you beat, according to scientists at Rice University.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Go here to see the original:
Scientists devise a new platform to overcome the limits of MRI contrast agents - Phys.Org

The global Nanomedicine market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Nanomedicine market player in a comprehensive way. Further, the Nanomedicine market report emphasizes the adoption pattern of the Nanomedicine across various industries.

The Nanomedicine market report examines the operating pattern of each player new product launches, partnerships, and acquisitions has been examined in detail.

Request Sample Report @https://www.mrrse.com/sample/3117?source=atm

market dynamics section of this report analyzes the impact of drivers and restraints on the global nanomedicine market. The impact of these drivers and restraints on the global nanomedicine market provides a view on the market growth during the course of the forecast period. Increasing research activities to improve the drug efficacy coupled with increasing government support are considered to be some of the major driving factors in this report. Moreover, few significant opportunities for the existing and new market players are detailed in this report.

Porters five forces analysis provides insights on the intensity of competition which can aid in decision making for investments in the global nanomedicine market. The market attractiveness section of this report provides a graphical representation for attractiveness of the nanomedicine market in four major regions North America, Europe, Asia-Pacific and Rest of the World, based on the market size, growth rate and industrial environment in respective regions, in 2012.

The global nanomedicine market is segmented on the basis of application and geography and the market size for each of these segments, in terms of USD billion, is provided in this report for the period 2011 2019. Market forecast for this applications and geographies is provided for the period 2013 2019, considering 2012 as the base year.

Based on the type of applications, the global nanomedicine market is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other applications. Other applications include dental, hematology, orthopedic, kidney diseases, ophthalmology, and other therapeutic and diagnostic applications of nanomedicines. Nanoparticle based medications are available globally, which are aimed at providing higher bioavilability and hence improving the efficacy of drug. There have been increasing research activities in the nanomedicine filed for neurology, cardiovascular and oncology applications to overcome the barriers in efficient drug delivery to the target site. Moreover, the global nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and Rest of the World. This section describes the nanomedicine support activities and products in respective regions, thus determining the market dynamics in these regions.

The report also provides a few recommendations for the exisitng as well as new players to increase their market share in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.

The global nanomedicine market is categorized into the following segments:

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/3117?source=atm

The Nanomedicine market report offers a plethora of insights which include:

The Nanomedicine market report answers important questions which include:

The Nanomedicine market report considers the following years to predict the market growth:

Buy This Report @ https://www.mrrse.com/checkout/3117?source=atm

Why Choose Nanomedicine Market Report?

Nanomedicine Market Reportfollows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

See original here:
Nanomedicine Market : Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Forecasts to 2025 - Jewish Life News

44 - Nanomedicine by Toni Castro
44 - Nanomedicine by Toni Castro.

By: Bruce Rasmussen

Go here to see the original:
44 - Nanomedicine by Toni Castro - Video

Profiles in Nanomedicine Research: Kohut

By: ISUengineering

Read this article:
Profiles in Nanomedicine Research: Kohut - Video

Nanomedicine is the medical application of nanotechnology that will hopefully lead to useful research tools, advanced drug delivery systems, and new ways to treat disease or repair damaged tissues and cells. Drug delivery is currently the most advanced application of nanotechnology in medicine. Nanoscale particles are being developed to improve drug bioavailability, a major limitation in the design of new drugs. Poor bioavailability is especially problematic with newer and still experimental RNA interference therapy. Lipid or polymer-based nanoparticles are taken up by cells due to their small size, rather than being cleared from the body. These nanoparticles can be used to shuttle drugs into cells which may not have accepted the drug on its own. The nanoparticle chaperone may also be able to specifically target certain cell types, possibly reducing toxicity and improving efficacy. Nanoparticles such as quantum dot nanocrystals are the size of a protein molecule or short stretch of DNA. Quantum dots can be engineered to absorb and emit many wavelengths of light with very sharp precision. This makes them ideal for protein-protein interaction studies as they can be linked to molecules to form long-lived probes. They can track biological events by tagging specific proteins or DNA in order to follow their progress through biological pathways. In medicine, quantum dots could be used for diagnostic purposes. Dendrimers are another interesting and powerful use of nanotechnology in medicine. Dendrimers are nanostructured synthetic molecules with a regular branching structure projecting from a central core. Dendrimers form one layer at a time so the size of the dendrimer is determined by the number of synthetic steps. Each dendrimer is usually only a few nanometers wide. The outside layer can be engineered to be composed of specific functional groups that can act as hooks to specifically bind other molecules such as DNA. Dendrimers may act as effective agents for delivering DNA into cells during gene therapy. While viral vectors typically trigger an immune response, in principle, dendrimers should not. Nanorobotics or molecular nanotechnology involves the creation of complex mechanical systems constructed from the molecular level. Richard Feynman was the first to propose using machine tools to make smaller machine tools which can make smaller machine tools down to the atomic level. DNA makes an ideal material for the construction of nanomachines due to its stiffness. The intermolecular interactions of DNA are well-known and can be easily predicted. The self-assembly of DNA further facilitates its use as a construction material. Dr. Nadrian Seeman pioneered the use of DNA as a construction material and can make virtually any regular 3D shape. In 1999 his group succeeded in building the first nanoscale robotic actuator from DNA. DNA and later, nanotubes, have been used to construct molecular tweezers which can be used to physically manipulate nanostructures. Research into the construction of nanomotors has advanced greatly and nanomotors will form an important part of future nanorobots. Carlo Montemagno at Cornell has mutated the central rotating shaft of ATPase to have metal-binding amino acids that allow the ATPase to bind to nanoscale nickel pedestals. A silicon bar 100 nanometers long was bound to the rotor subunit of each ATPase by self-assembly, creating an ATP-powered molecular motor. These nanorobots may eventually form sophisticated cellular factories, used to synthesize drugs, repair damaged DNA, and releasing drugs on command.

More:

Nanomedicine Research

WEST HARTFORD, Conn., April 17, 2014 /PRNewswire-iReach/ --

Global Information Inc. announces the addition of a new market research report "Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" at GIIResearch.com

This report includes market estimations for nanomedicine market for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019.

The overall nanomedicine market is segmented on the basis of application and geography and the market estimations for each of these segments, in terms of USD billion, is provided in this report.

The nanomedicine market, by applications is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other markets. The nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and rest of the world.

Table of Contents

Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Nanomedicine Market Overview Chapter 4 Global Nanomedicine Market, by Applications Chapter 5 Global Nanomedicine Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles List of Tables and Figures

More detailed information is available at http://www.giiresearch.com/report/tsm294638-nanomedicine-market-neurology-cardiovascular-anti.html

Media Contact: Joe Malley, Global Information, Inc., 860-674-8796, US-marketing@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

Read more:

Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global ...

NANOMEDICINE 3 Quantum Dot Technology for Multiplexing Applications#

By: NanoMedicine

Read the rest here:

NANOMEDICINE 3 Quantum Dot Technology for Multiplexing Applications# - Video

Regulatory News:

NANOBIOTIX (Euronext: NANO ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, today announced that it has been selected by the American Society of Clinical Oncology (ASCO) to present data from its clinical trial evaluating NBTXR3 in advanced soft tissue sarcoma.

The clinical trial will be presented during the congress session dedicated to sarcoma.

This years ASCO will take place in Chicago from 31 May to 3 June, 2014. The Annual Meeting brings together more than 25,000 oncology professionals from a broad range of clinical research specialties.

The NBTXR3 study was selected from over 5,500 abstracts received by the Scientific Program Committee of ASCO for review.

Laurent Levy, CEO of Nanobiotix said: We are honored that ASCO has invited us to present our NBTXR3 data in front of the international oncology community. This is an encouraging step for our team and our partners and we will continue to develop innovative therapies aimed to improve patient care in the fight against cancer.

About NANOBIOTIX - http://www.nanobiotix.com

Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer. The Companys first-in-class, proprietary technology, NanoXray, enhances radiotherapy energy to provide a new, more efficient treatment for cancer patients. NanoXray products are compatible with current radiotherapy treatments and are meant to treat a wide variety of cancers via multiple routes of administration.

Nanobiotixs lead product NBTXR3, based on NanoXray, is currently under clinical development for soft tissue sarcoma and locally advanced head and neck cancer. The Company, based in Paris, France, has partnered with PharmaEngine for clinical development and commercialization of NBTXR3 in Asia.

Nanobiotix is listed on the regulated market of NYSE Euronext in Paris (ISIN: FR0011341205, Euronext ticker: NANO, Bloomberg: NANO: FP).

Go here to read the rest:

Nanobiotix Selected to Present Data from NBTXR3 Clinical Trial at the 50th Annual Meeting of the American Society of ...

Nanomedicine Book Site

1996-2013 Robert A. Freitas Jr. All Rights Reserved

Nanomedicine, Volume IIA: Biocompatibility by Robert A. Freitas Jr. is now available in hardcover for $99 + shipping. Click here to purchase the book at Amazon.com or click here for information or to purchase the book directly from Landes Bioscience.

Nanomedicine, Volume I: Basic Capabilities by Robert A. Freitas Jr. is now available in softcover for $89 + shipping. Click here for information or to purchase the book directly from Landes Bioscience.

About Nanomedicine (the field)

Molecular nanotechnology has been defined as the three-dimensional positional control of molecular structure to create materials and devices to molecular precision. The human body is comprised of molecules, hence the availability of molecular nanotechnology will permit dramatic progress in human medical services. More than just an extension of "molecular medicine," nanomedicine will employ molecular machine systems to address medical problems, and will use molecular knowledge to maintain and improve human health at the molecular scale. Nanomedicine will have extraordinary and far-reaching implications for the medical profession, for the definition of disease, for the diagnosis and treatment of medical conditions including aging, and ultimately for the improvement and extension of natural human biological structure and function.

Read more here:

Nanomedicine, Volume 1: Basic Capabilities

Panel - The Regulation Environment in Nanomedicine -- The Step to the Last Phase of Translation
Participants: -Dr. Falk Ehmann, Scientific Support and Projects, European Medicines Agency, London (UK) -Dr. Kumiko Sakai-Kato, National Institute of Health ...

By: TAUVOD

Read the original here:

Panel - The Regulation Environment in Nanomedicine -- The Step to the Last Phase of Translation - Video

Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics
Chair Prof. Dr. Jan Mollenhauer, NanoCAN, University of Southern Denmark, (DK) Speaker: Prof. Dr. Kostas Kostarelos, FRSM, FIoN, FRSA, Chair of Nanomedicine,...

By: TAUVOD

Read the original:

Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics - Video

image:Left: Primary tumor or overt metastasisCenter: Center: Pre-metastatic nicheRight: Post-surgical wound view more

Credit: 2021 Innovation Center of NanoMedicine

Summary:Matrix metalloproteinases (MMPs) is an enzyme required for cancer cells to metastasize/invade, and cancer cells with higher MMP activity have higher metastasis ability and progress quickly.In this study, we created polymersomes (smart nanomachines) that act specifically in tissues that overproduce MMPs, prevent cancer metastasis, and developed a method to remove residual tumor tissue that could not be visually confirmed after surgery.We simultaneously loaded the cell division inhibitor colchicine and the MMP inhibitor marimastat into MMPs-responsive polymersomes as an enzymatically transformable nanomachine designed to achieve transformation following dePEGylation by cleavage of the inserted substrate peptide by MMPs. The effect on malignant tumors with high MMPs activity was evaluated.During transformation, nanomachines with exposed guanidine residues easily penetrate into cells, and at the same time, by releasing the contained drugs, it exerts an anti-cancer effect.Evaluating drug uptake using HT1080 cells derived from human fibrosarcoma that overproduce MMPs, studying pharmacokinetic and nano-bio interaction using a confocal laser scanning biomicroscope and evaluating metastasis inhibitory effect using triple-negative breast cancer transplantation model, the results were published in Advanced Materials (IF = 30.849 in 2021).

J. Li, Z. Ge, K. Toh, X. Liu, A. Dirisala, W. Ke, P. Wen, H. Zhou, Z. Wang, S. Xiao, J. F. R. Van Guyse, T. A Tockary, J. Xie, D. G.-Carter, H. Kinoh, S. Uchida, Y. Anraku, and K. Kataoka, Advanced Materials, 2021.DOI: 10.1002/adma.202105254URL: https://onlinelibrary.wiley.com/doi/10.1002/adma.202105254

October 8, 2021, Kawasaki (Japan) and Hefei (China): The Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion (Director General: Kazunori KATAOKA, location: Kawasaki-ku, Kawasaki-City; abbreviated name: iCONM), in collaboration with the Chinese Academy of Science (CAS) Key Laboratory of Soft Matter Chemistry (USTC: University of Science and Technology), has created nanomachines that detect MMPs (matrix metalloproteinases), a principal enzyme for cancer cells to invade normal tissue, and deliver anticancer drugs according to an announcement in the journal Advanced Materials (IF = 30.849). As it can target highly invasive cancer cells, it is expected to inhibit cancer metastasis and recurrence.

Cancer is known as a malignant tumor due to its characteristics of metastasis, recurrence, and invasion, and preventing them is one of the most effective ways for treatment. When cancer cells metastasize, they need to pass through (invade) normal tissues, and in doing so, they use extracellular proteases (proteolytic enzymes) called MMPs to destroy the fibrous tissue (matrix) that binds cells to cells and tissues to tissues. In this study, we focused on tissues and cells that overproduce MMPs and incorporated the cell division inhibitor colchicine and the MMP inhibitor marimastat into MMPs-responsive polymersomes as an enzymatically transformable nanomachine (ETN). The ETN was designed to possess an amino acid sequence that serves as a specific cleavage site for MMPs and thus be capable of releasing the PEG and exposing the guanidine residue after cleavage. In the drug uptake experiment using human fibrosarcoma-derived HT1080 cells, we found that the fluorescently labeled ETN (Cy5-ETN) had a 10-fold higher uptake than that of an inert vehicle without enzymatic transformation behavior. High cellular uptake enabled strong cytotoxicity of colchicine-loaded ETN with IC50 = 0.015 M compared to the inert vehicle with IC50 = 0.402 M.Observation of mice treated with ETN using confocal laser scanning biomicroscopy showed no leakage out of blood vessels in the auricle and normal liver; strikingly, the nanomachines were found to extensively invade the tumor-associated tissues in breast cancer with high MMPs expression.

In pharmacological experiments with mice, we evaluated the antitumor effect for primary and secondary tumor using MDA-MB-231/LM2 (human) and 4T1 (mice) triple-negative breast cancer models. As a result, the ETN simultaneously encapsulating with colchicine and marimastat had a strong antitumor effect and prolonged survival in both triple-negative breast cancer models. In addition, on the basis of metastasis-prone phenotype of this model after orthotopic transplantation, the ETN was also confirmed to efficiently inhibit lung metastasis because of residual tumor targetability. Our results prove an applicable technology for not only to cancers but also to other diseases with high expression of MMPs.

Kawasaki Institute of Industrial Promotion (KIIP)Kawasaki Institute of Industrial Promotion was established in 1988 funded 100% from Kawasaki City for the purpose of coping with the hollowing out of industry and changes in the demand structure. In order to realize a higher level of market development, transforming R&D type companies, training technological capabilities to support it, human resources development, understanding market needs, etc., by utilizing the functions of the Kawasaki, KIIP has been contributing to revitalize the local economy by promoting exchanges of local industry information, advancing technology and corporate exchanges with establishment of a R&D institutions, developing creative human resources through workshops and promoting businesses such as expanding sales channels through exhibition business.https://www.kawasaki-net.ne.jp/

Innovation Center of NanoMedicine (iCONM)Innovation Center of NanoMedicine (iCONM) started its operation in April 2015 as a core research center in life science field at King SkyFront on the request of Kawasaki city that KIIP utilized national policies as a business operator and proposer. It is a unique research center that the world has ever seen which is designed for the purpose of promoting open innovation through industry-academia-government/medical-engineering collaboration, prepared with state-of-the-art facilities and experimental equipment, that enables comprehensive research and development from organic synthesis / microfabrication to preclinical testing.iCONM: https://iconm.kawasaki-net.ne.jp/en/index.html

University of Science and Technology of China (USTC)The University of Science and Technology of China (USTC) is a public research university of China with scientific and technological research as core strength, under the leadership of the Chinese Academy of Sciences (CAS). Its foundation in 1958 was hailed as "A Major Event in the History of Chinese Education and Science.". USTC has three National Research Institutions and 6 State Key Laboratories and 18 Key Laboratories of the CAS. USTC actively promotes cooperation and exchange with around 100 universities and research institutions in more than 30 nations and regions. In recent years, USTC is ranked in the world's top 100 universities in the most-widely read university rankings.USTC: http://en.ustc.edu.cn

October 8, 2021

Advanced Materials

Enzymatically Transformable Polymersome-Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer

7-Oct-2021

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Read the original post:
Creating smart nanomachines to detect highly invasive cancer after surgery and prevent recurrence - EurekAlert

Nanomaterials are a significant and diversified class of materials with use in nearly every major economic sector, including production, health, and power. Every year, the use of synthesized nanoparticles in consumer items grows rapidly.

Image Credit:LuckyStep/Shutterstock.com

Within industrial production or research laboratories environment, thermo-analytical analyses are frequently used to provide precise data on nanomaterials, such as insinuating material composition and nanoparticle purity, as well as crystallinityand formation kinetics of nanoparticles.

Before implementing nanoparticles in anyprocess,the most crucial factor in evaluating isnanoparticle purity. Thermal analysis is an efficient method for assessing the purity of nanoparticles by decomposing the material with little specimen preparation.

Nanoparticle modifications, such as the insertion of surface properties, can also be evaluated between chemical changes. Identifying the chemical constituents of nanoparticles, particularly during production and fabrication, is a key aspect in assessing nanomaterial purity.

Some nanomaterials are synthesized using solution-based techniques, in which components combine to form the product, with nanoparticles developing as the substance crystallizes. Chemical vapor deposition (CVD) and physical vapor deposition (PVD) are used to make other nanoparticles.

Some nanoparticle production processes rely on the trapping of other molecules, resulting in nanoparticle productionwith undetermined contents. In these circumstances, knowing how much of each constituent is present is critical for establishing nanoparticle purity.

TGA can be utilizedto determine the final concentration of nanoparticles by examining their constituents (mass percentage of each component). Centrifugation or other strategies must be used to separate the nanoparticle substances from the encapsulating solvent.

Increasing the temperatureand comparing the combustion thermal transitions to pure components can reveal its chemical composition.Information about nanoparticle morphology and size may be required to determine total mass loss per nanoparticle using thermogravimetric analysis (TGA) or differential scanning calorimetry (DSC). DSC and TGA can be used to determine the purity of synthesized nanomaterials by comparing them to standards.

TGA is one of the fastest ways for determining the relative amounts of pure carbon, bonded hydrocarbons, structured carbon, and heterogeneous catalyst particles in a carbon nanotube (CNT) sample material.

Amorphous carbons oxidizeat around 200 C., single-wall CNTsat 400 C., multi-wall CNTs at 600 C., and anything above 650 degrees Celsius is due to a solid catalyst and its oxidants.

TGA can offer a measurement of purity for CNT particles by calculating the amount of the material that degrades at a suitable temperature range. TGA is also useful for evaluating the thermal behaviorof carbon nanotubes in an oxidizing atmosphere.

Thermal analysis offers a variety of benefits that make it a useful complement to other nanomaterials analytical techniques. Nanoparticle sample preparation (i.e., specimen quantity) is typically minimal, and no additional changes such as luminous labeling are required to implement the examination. TGA, DSC, and other colorimetry methods are among the techniques that can be used.

Thermal analysis can be used in industrial settings to investigate the purityof nanoparticles because industrial equipment is accessible and interpretation of the data is often simple. The purityof nanoparticles may be determined rapidly in the lab with little specimen preparation, and the findings can be matched to other analytical techniques for extra assurance.

Thermal techniques can also be used to detect activities that might alter nanoparticle purity, such as when the nanoparticle is subjected to liquid or a biological environment. As more complex synthesis procedures are used, the dynamics of nanoparticle excitons are becoming increasingly essential. Nanoparticle systems, such as nanostructured materials, can have their composition and reaction kinetics compared to their nanoparticle content and purity.

One technology that is making development in the implementation of nanomaterial products is nano-calorimetry. Nano-calorimetry is a sensor-basedsystem able to measure samples of nanoliters in volume or milligrams to nanograms in weight with a precision of less than five nW for measuring transition temperature.

Analyses of as-produced specimens and their relationship with the environment, as well as contacts between nanomaterials and organisms, are achievable because of the small sample volumes, which is essential in the field of nanomedicine.

TGA has also made significant progress in terms of delivering nanoscale breakdown information. Microscale TGAcanbe used to detect CNT deterioration, as well as quantitative investigations of coating on gold and quartz nanoparticles. Thedata obtainedcan be linked to traditional TGA or other analytical results.

For the investigation of nanomaterials and applications incorporating nanoparticles, thermal analysis approaches are now extensively used. To make thermal analysis techniques more suited for nanoparticle systems, upgrades should be considered. It is critical to be able to minimizesample sizes, increase susceptibility, and evaluate nanomaterial-matrix interaction. Due to recent improvements in thermos-analytical techniques, nanoparticle evaluation on small scales is now attainable.

Thermal Analysis; A Useful Tool for Nanocomposite Analysis

Mansfield, E. (2015). Recent advances in thermal analysis of nanoparticles: Methods, models and kinetics.Modeling, Characterization, and Production of Nanomaterials, 167-178. https://doi.org/10.1016/B978-1-78242-228-0.00006-5

Mansfield, E., Tyner, K. M., Poling, C. M., & Blacklock, J. L. (2014). Determination of nanoparticle surface coatings and nanoparticle purity using microscale thermogravimetric analysis.Analytical chemistry,86(3), 1478-1484. https://doi.org/10.1021/ac402888v

Mansfield, E., Kar, A., & Hooker, S. A. (2010). Applications of TGA in quality control of SWCNTs.Analytical and bioanalytical chemistry,396(3), 1071-1077. https://10.1007/s00216-009-3319-2

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

See original here:
Establishing Nanoparticle Purity with Thermal Analysis - AZoNano

A new study by researchers atThe Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(OSUCCC James) shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.RNA nanoparticles show great promise for the targeted delivery of anticancer drugs. Understanding their structure and behavior is essential for their possible future use.

This study, published in the journalACS Nano, reveals that RNA nanoparticles have elastic and rubbery properties that enable the molecules to stretch and return to their normal shape. Researchers say that these properties could help the particles target tumors by enabling them to slip through the poorly formed walls of tumor blood vessels and enter a tumor mass.

The researchers further proved that the same rubbery properties enable the RNA nanoparticle to slip through the kidneyfiltersto excrete into the urine half an hour after systemic injection, thereby eliminating them from the body relatively quickly. That, in turn, could reduce retention of the anticancer agent in vital organs, lowering an agents toxicity.

We show that RNA nanoparticles have a flexibility that allows for the assembly of molecular structures that have stretchable angles, says study leader and corresponding authorPeixuan Guo, PhD, professor in the College of Pharmacy and theSylvan G. Frank Endowed Chair in Pharmaceutics and Drug Delivery. Guo also is in the OSUCCC JamesTranslational Therapeutics Research Program.

These findings demonstrate the rubbery properties of RNA nanoparticles and why these molecules hold great promise for industrial and biomedical applications, especially as carriers for targeted delivery of anticancer drugs, says Guo, who directs Ohio StatesCenter for RNA Nanobiotechnology and Nanomedicine.

For this study, Guo and his colleagues tested the elasticity of nucleic acid polymers by stretching and relaxing individual RNA nanoparticle, while subjecting RNA nanoparticles to elasticity studies using dual-beam optical tweezers built in Guo lab. Finally, they used animal models to study the biodistribution, excretion and retention of RNA nanoparticles. This included measuring excretion of the particles in urine, along with the study on the effect of their shape and size.

Key findings include:

RNA nanoparticles are stretchable and shrinkable, like rubber, even after repeated extension and relaxation with multiple repeats by optical tweezers.

In animal models, RNA nanoparticles show stronger cancer targeting and lower accumulation in healthy organs when compared to gold and iron nanoparticles of similar size.

Also in animal models, within half hour after systemic injection, RNA nanoparticles that were 5, 10 and 20 nm in size were filtered by the kidneys and retained their original structure in urine, even though the upper limit of kidney pore size for filtration is generally 5.5 nm. This suggests that the larger RNA nanoparticles slipped like rubber and amoeba through filtration pores, then returned to their original size and shape in urin.

Overall, Guo says, we believe these findings further support the development of RNA nanoparticles for targeted delivery of anticancer drugs or therapeutic RNA.

Grants from the National Institutes of Health (EB019036, CA151648 and CA207946) supported this research.

Other researchers involved in this study were Chiran Ghimire, Hongzhi Wang, Hui Li, Mario Vieweger and Congcong Xu, The Ohio State University.

About the OSUCCC James:

The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI.

As the cancer programs 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked byU.S. News & World Reportand has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors and more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care.

More here:
Ohio State study shows rubbery properties help RNA nanoparticles target tumors efficiently and quickly leave body - The Highland County Press

The Nanomedicine Market by revenue is expected to grow at a CAGR of over 8.5% during the forecast period 20202027 and is poised to reach US$XX Million in terms of Value.We at Decisive Markets Insights appreciate those firms which are actually interested in purchasing the Nanomedicine report. There has been a recent developments in the above market which is going to impact your revenues big time and help you gain an edge over the competition.

Take first step by requesting for a discount which will vary between 15% to 25% depending on how soon you require to buy the report.

To inquire about the discount, kindly fill the form by clicking on the link below:-https://decisivemarketsinsights.com/nanomedicine-market/16196006/request-discount

Summary of the Report

Increasing demand, rising product acceptance and improving research and development are some of the key factors boosting the growth of the market. The market is growing at a significant growth rate at present and is expected to remain so during the forecast period as well.

To avail Sample Copy of report, visit @ https://decisivemarketsinsights.com/nanomedicine-market/16196006/request-sample

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):Regenerative MedicineIn-vitro & In-vivo DiagnosticsVaccinesDrug Delivery

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):GE HealthcareJohnson & JohnsonMallinckrodt plcMerck & Co. Inc.Nanosphere Inc.Pfizer Inc.Sigma-Tau Pharmaceuticals Inc.Smith & Nephew PLCStryker CorpTeva Pharmaceutical Industries Ltd.UCB (Union chimique belge) S.A

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):Clinical CardiologyUrologyGeneticsOrthopedicsOphthalmology

Nanomedicine Market Scope and Segmentation of the Market

The key segments covered in the report are mentioned below:

By type By Market By Application By End-Use By Geography

The reports regional analysis includes countries in Asia, North America, Europe, South America, Central America, the Middle East and Africa. We also covered countries such as France, Singapore, South America, Canada, Russia, Mexico, the United States, Italy, the Middle East, Central America, Japan, the United Kingdom, India, Germany, Africa, Germany, Africa, China, South Korea, and, among others, Taiwan in these big geographies. The year-on-year growth is given for all segments and sub-segments from 2019 to 2027.

If you want to inquire before buying, kindly click on the link @ https://decisivemarketsinsights.com/nanomedicine-market/16196006/pre-order-enquiry

Nanomedicine Market Overview, Key Trends Market Dynamics

Some of the main factors driving the growth of the market are growing demand, increasing product acceptance and improving research and development. The market is currently rising at a substantial growth rate and is expected to remain so throughout the forecast period as well. The market appears to be marginally affected by COVID -19 at the moment; however, the market is expected to recover its normal pace over time in the coming years. Competitive landscape, study of market share, size, outlook and competitive landscape.

Regional Coverage of Global Nanomedicine Market

North America US, Mexico, Canada Europe Russia, Ukraine, France, Spain, Sweden, Norway, Germany, Finland, Poland, Italy, United Kingdom, Greece, Austria, Denmark, Switzerland, Netherlands, Belgium, Turkey, Luxembourg Asia-Pacific China, Japan, India, Australia, South Korea, Taiwan, Malaysia, Philippines, Thailand, Singapore South America- Brazil, Argentina, Peru, Chile Middle East and Africa Bahrain, Egypt, Israel, Kuwait, Qatar, Saudi Arabia, United Arab Emirates, South Africa

COVID -19 Impact Analysis

The report also offers a detailed insight of COVID-19 impact analysis: Before COVID-19 Present Scenario Post recovery of COVID-19

Table of Content

Customization can be availed on Request:

Chapter 1: Introduction and ScopeChapter 2: Key Company ProfilesChapter 3: Market Descriptions, Share and Forecast across type, application and geographyChapter 4: Market Descriptions of Asia Pacific regionChapter 5: Market Descriptions of Europe regionChapter 6: Market Descriptions of Asia Pacific regionChapter 7: Market Descriptions of North America regionChapter 8: Market Descriptions of Middle East and Africa regionChapter 9: landscapes of the marketChapter 10: Key OpportunitiesChapter 11: Strategies by the key players

Key Pointers of the Report

Decisive Markets Insights advises what your approach should be.Key winning techniques embraced by the major playersMarket analysis from 360 degree perspectivesEstimation and Prognosis, 2020-2027Market growth rate and market size from 2020 to 2027An added portion in the study was COVID-19 impact analysis.

Additional Pointers of the Report:

Market Attractiveness Analysis SWOT Analysis Porters Five Analysis PEST Analysis Value Chain Analysis

Kindly contact us and our expert will get back to you within 30 minutes:

Decisive Markets InsightsSunil KumarSales HeadEmail [emailprotected]US +18317045538UK +441256636046

Continued here:
Nanomedicine Market to Rise with Impressive CAGR | Players Merck & Co. Inc., Nanosphere Inc., Pfizer Inc. KSU | The Sentinel Newspaper - KSU |...

Global Nanorobotics Market was valued at US$ 3.7 Bn in 2018 and is expected to reach US$ 9.2Bn by 2026, at a CAGR of 12.06%during a forecast period.

Developments in nanotechnology coupled with demand for minimally aggressive procedures are expected to drive market growth over the forecast period. Nanobots possess likely in the medical sector for destroying cancerous cells at the genetic level. Increasing support for nanomedicine by many nations and the increasing geriatric population are factors which can augur market demand.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/30888

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Utilization of nanobots in the ranostics can be beneficial for the market in the near future. A rise in miniaturization and demand for automation across various sectors are anticipated to fuel market growth. Training of new personnel to use nanobots can restrain market growth in the upcoming years.Nanomedicine application segment to grow at the highest CAGR during the forecast period. Nanorobotics is widely used in nanomedicine owning to its healthcare features. The large share of this application aspects to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, biomaterial, in vitro diagnostic, active implants, and drug therapy.

North America region accounted for the largest share of 12.2%, in terms of value, of the nanorobotics market globally. Presence of many nanotechnology companies, well-developed healthcare infrastructure, and government initiatives to create patient awareness are factors driving the market. The U.S is anticipated to contribute to market revenue owing to the increase in cardiovascular diseases and the rising elderly populace.

Europe follows North America as the second biggest nanorobotics market. Presence of chronic diseases and the burgeoning population are factors expected to indicate the Europe nanobots market. Establishment of organizations to develop standards pertaining to nanotechnology can expand market growth. In 2018, DNA-Robotics, an organization including 12 European companies, has outlined steps to expedite production of nanobots on a large scale. These standards can help scale the market exponentially in the upcoming years.

A recent development in nanorobotics market: In March 2018, Thermo Fisher Scientific acquired Gatan, an exclusively owned subsidiary of Roper Technologies. Gatan is an electron microscopy solutions provider in the U.S, which accompaniments the Thermo Fisher Scientifics electron microscopy solutions business.In March 2017, Oxford Instruments (U.K) Asylum Research introduced its new SurfRider HQ-Series of high quality, budget-priced AFM probes, which are also existing in a model suitable for nanomechanical image mode.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Nanorobotics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Nanorobotics Market.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/30888

Scope of the Global Nanorobotics Market

Global Nanorobotics Market, By Type

Nanomanipulatoro Electron Microscope (EM) Scanning Electron Microscope (SEM) Transmission Electron Microscope (TEM)o Scanning Probe Microscope (SPM) Atomic Force Microscopes (AFM) Scanning Tunneling Microscope (STM) Bio-Nanorobotics Magnetically Guided Bacteria-BasedGlobal Nanorobotics Market, By Application

Nanomedicine Biomedical Mechanical OthersGlobal Nanorobotics Market, By Region

North America Europe Asia Pacific Middle East and Africa South AmericaKey players operating in Global Nanorobotics Market:

Bruker JEOL Thermo Fisher Scientific Ginkgo Bioworks Oxford Instruments EV Group Imina Technologies Toronto Nano Instrumentation KlockeNanotechnik KleindiekNanotechnik Xidex Synthace Park Systems Smaract Nanonics ImagingKey Innovators:

Novascan Technologies Angstrom Advanced Hummingbird Scientific NT-MDT Spectrum Instruments Witec

MAJOR TOC OF THE REPORT

Chapter One: Nanorobotics Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanorobotics Market Competition, by Players

Chapter Four: Global Nanorobotics Market Size by Regions

Chapter Five: North America Nanorobotics Revenue by Countries

Chapter Six: Europe Nanorobotics Revenue by Countries

Chapter Seven: Asia-Pacific Nanorobotics Revenue by Countries

Chapter Eight: South America Nanorobotics Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanorobotics by Countries

Chapter Ten: Global Nanorobotics Market Segment by Type

Chapter Eleven: Global Nanorobotics Market Segment by Application

Chapter Twelve: Global Nanorobotics Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanorobotics Market Report at:https://www.maximizemarketresearch.com/market-report/global-nanorobotics-market/30888/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [emailprotected]

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

See the original post here:
Global Nanorobotics Market : Industry Analysis and Forecast (2019-2026) by Type, Application, and Region - Galus Australis

The global Nanomedicine market focuses on encompassing major statistical evidence for the Nanomedicine industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Nanomedicine study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.

This intelligence and 2026 forecasts Nanomedicine industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedented growth trajectory for the Nanomedicine market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.

Moreover, the Nanomedicine report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Nanomedicine market, business trends, potential revenue sources, and upcoming market opportunities.

Download PDF Sample of Nanomedicine Market report @ https://hongchunresearch.com/request-a-sample/2923

Major Players in Nanomedicine market are:, Fraunhofer ICT-IMM, Tecnalia, Bergmannstrost, CIC biomaGUNE, Bracco, Affilogic, LTFN, GIMAC, Endomagnetics, Materials Research Centre, VITO NV, CIBER-BBN, Istec CNR, Carlina technologies, Cristal Therapeutics, ChemConnection, IMDEA, SwedNanoTech, Grupo Praxis, Vicomtech, DTI, Tekniker, Biotechrabbit, Contipro, , Major Regions that plays a vital role in Nanomedicine market are:, North America, Europe, China, Japan, Middle East & Africa, India, South America, Others

Most important types of Nanomedicine products covered in this report are:, Type 1, Type 2, Type 3, Type 4, Type 5

Brief about Nanomedicine Market Report with [emailprotected] https://hongchunresearch.com/report/Nanomedicine-market-2923

Most widely used downstream fields of Nanomedicine market covered in this report are:, Application 1, Application 2, Application 3, Application 4, Application 5

The Nanomedicine market study further highlights the segmentation of the Nanomedicine industry on a global distribution. The report focuses on regions of North America, Europe, Asia, and the Rest of the World in terms of developing business trends, preferred market channels, investment feasibility, long term investments, and environmental analysis. The Nanomedicine report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.

In addition, the Nanomedicine market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Nanomedicine market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.

The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Nanomedicine industry as it explores the competitive nature of the market complete with a regional analysis.

Some Point of Table of Content:

Chapter One: Nanomedicine Introduction and Market Overview

Chapter Two: Industry Chain Analysis

Chapter Three: Global Nanomedicine Market, by Type

Chapter Four: Nanomedicine Market, by Application

Chapter Five: Global Nanomedicine Production, Value ($) by Region (2014-2019)

Chapter Six: Global Nanomedicine Production, Consumption, Export, Import by Regions (2014-2019)

Chapter Seven: Global Nanomedicine Market Status and SWOT Analysis by Regions

Chapter Eight: Competitive Landscape

Chapter Nine: Global Nanomedicine Market Analysis and Forecast by Type and Application

Chapter Ten: Nanomedicine Market Analysis and Forecast by Region

Chapter Eleven: New Project Feasibility Analysis

Chapter Twelve: Research Finding and Conclusion

Chapter Thirteen: Appendix continued

List of tablesList of Tables and Figures

Figure Product Picture of Nanomedicine

Table Product Specification of Nanomedicine

Figure Market Concentration Ratio and Market Maturity Analysis of Nanomedicine

Figure Global Nanomedicine Value ($) and Growth Rate from 2014-2024

Table Different Types of Nanomedicine

Figure Global Nanomedicine Value ($) Segment by Type from 2014-2019

Figure Nanomedicine Type 1 Picture

Figure Nanomedicine Type 2 Picture

Figure Nanomedicine Type 3 Picture

Figure Nanomedicine Type 4 Picture

Figure Nanomedicine Type 5 Picture

Table Different Applications of Nanomedicine

Figure Global Nanomedicine Value ($) Segment by Applications from 2014-2019

Figure Application 1 Picture

Figure Application 2 Picture

Figure Application 3 Picture

Figure Application 4 Picture

Figure Application 5 Picture

Table Research Regions of Nanomedicine

Figure North America Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Figure Europe Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Table China Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Table Japan Nanomedicine Production Value ($) and Growth Rate (2014-2019)continued

About HongChun Research:HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details:Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Go here to read the rest:
COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research...

Nanomedicine Market Scope of the Report:

Factors and Nanomedicine Market execution are analyzed using quantitative and qualitative approaches to give a consistent picture of current and future trends in the boom. The study also allows for a detailed market analysis focused primarily on geographic locations. The Global Nanomedicine Market Report offers statistical graphs, estimates, and collateral that explain the state of specific trade within the local and global scenarios.

The worldwide market for Nanomedicine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2025, from xx million US$ in 2018, according to a new study.

This report focuses on the Nanomedicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

For more insights into the Market, request a sample of this report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2734725&source=atm

segment by Type, the product can be split intoQuantum dotsNanoparticlesNanoshellsNanotubesNanodevicesMarket segment by Application, split intooncologyInfectious diseasesCardiologyOrthopedicsOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

For Information On The Research Approach Used In The Report, Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2734725&source=atm

Reasons to Purchase this Nanomedicine Market Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis

* Market dynamics scenario, along with growth opportunities of the market in the years to come

* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects

* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.

* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment

* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years

* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

* 1-year analyst support, along with the data support in excel format.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2734725&licType=S&source=atm

The Nanomedicine Market report has 150 tables and figures browse the report description and TOC:

Table of Contents

1 Study Coverage

1.1 Nanomedicine Product

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Nanomedicine Market Size Growth Rate by Type

1.5 Market by Application

1.5.1 Global Nanomedicine Market Size Growth Rate by Application

2 Executive Summary

2.1 Global Nanomedicine Market Size

2.1.1 Global Nanomedicine Revenue 2014-2025

2.1.2 Global Nanomedicine Production 2014-2025

2.2 Nanomedicine Growth Rate (CAGR) 2019-2025

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Key Nanomedicine Manufacturers

2.3.2.1 Nanomedicine Manufacturing Base Distribution, Headquarters

2.3.2.2 Manufacturers Nanomedicine Product Offered

2.3.2.3 Date of Manufacturers Enter into Nanomedicine Market

2.4 Key Trends for Nanomedicine Markets & Products

3 Market Size by Manufacturers

3.1 Nanomedicine Production by Manufacturers

3.1.1 Nanomedicine Production by Manufacturers

3.1.2 Nanomedicine Production Market Share by Manufacturers

3.2 Nanomedicine Revenue by Manufacturers

3.2.1 Nanomedicine Revenue by Manufacturers (2019-2025)

3.2.2 Nanomedicine Revenue Share by Manufacturers (2019-2025)

3.3 Nanomedicine Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

More Information.

For More Information Kindly Contact:

ResearchMoz

Mr. Rohit Bhisey,

90 State Street,

Albany NY,

United States 12207

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

See the article here:
Nanomedicine Market Revolutionary Trends 2025 The News Brok - The News Brok

Imagine a world in which a tiny nanorobot could deliver a specific cannabinoid directly to your endocannabinoid (ECS) receptors. The nanorobot would be thousands of times smaller than the breadth of a human hair and could carry its small cargo inside a single droplet of liquid to deliver it directly to a target cell such as a cancer cell.

Sound far-fetched? It may be closer than you think, because researchers are making great strides in the fascinating field of nanomedicine.

The cannabis plant contains an amazing group of cannabinoids, terpenes, and flavonoids, and scientists are only beginning to unlock the complex pharmacology and potential of these compounds. Combined with nanomedicine, cannabis has even more potential to treat disease and provide overall health benefits for people.

Scientists can manipulate substances on an atomic scale, in the range of 1-100 nanometers, or one thousand times thinner than a sheet of paper. According to the US Nanotechnology Initiative, substances on the nanoscale have very different properties than bulk substances dounique properties like better electrical conductance, higher strength, and different magnetic properties, light reflection, or chemical reactivity. Nanotechnology can be performed on solids, liquids, or gases to unlock these unique phenomena.

For these reason, nanotechnology applications in medicine offer exciting promise and possibilities, especially when applied to cannabis compounds. Many nanotechnology applications are already in usecomputer circuits made from carbon nanotubes allow for far greater computing power, and nanoparticles are already being used in pharmaceuticals to improve absorption.

Researchers work on all kinds of aspects of nanotechnology, such as finding the best substance for nanoparticles, the best shape for a nanoparticle for a specific delivery, and the best transfer mechanisms for specific drugs. Nanoparticles can generate heat, deliver stem cells, be radioactive or metallic, and so much more.

While many applications are still only imagined by scientists, at its full potential, nanotechnology could be the next medical revolution, vastly changing how diseases are detected and treated.

One of the best applications of nanomedicine is in the area of drug delivery, whereby nanoparticles deliver substances directly to specific cells, like diseased cancer cells. Researchers can engineer nanoparticles to be attracted to a diseased cell and limit the ability to bind with and therefore damage healthy cells.

Scientists at MIT and other institutions have successfully used specific nanoparticles to deliver drugs to tumors. Even more interesting is that nanoparticles are developed to work togetherwhile one locates a tumor, another can use the signal from the first to effectively carry the drug to its intended target.

In one interesting application, scientists have created a nanoparticle that looks for hydrogen peroxide present in inflamed tissue, then it releases a drug in that environment to target heart disease.

There is great promise that nanotechnology and cannabinoids can make an impact on diseases like cancer, multiple sclerosis, Parkinsons, diabetes, and a wide range of serious inflammatory diseases.

Nanotechnology can help identify a disease at an early stage, perhaps even when a single cell has gone awry, and then deliver a targeted cannabinoid to correct a cells behavior, thus stopping the disease in its tracks. It may even be possible for a nanorobot to target a specific endocannabinoid receptor to shut down the entire inflammatory process for the betterment of a patient.

Cannabinoid nanodelivery systems have entered the research mainstream, with scientists working on biologically engineered cannabinoids and other nanoparticles to be transported to cells, and by creating nanocarrier transport substances out of metallics or other substances.

Delivery system research also touches on improving bioavailabilitythe rate at which the active substance of a drug enters the bloodstreamas well as improving the physical stability of nanoparticles and optimizing routes of administration, including injection, pills, or sublingual drops.

A nanotechnology-based targeted drug delivery system can be formulated to deliver cannabinoids directly to endocannabinoid receptors, where the magic happens. Cannabinoids can be packed inside a nanoparticle and carried to its intended target without degradation and with a controlled release.

For example, nanoemulsions are already used in the food industry to deliver probiotics or other bioactive ingredients in a very controlled release. These nanoemulsions use a combination of two liquids that dont normally combinesuch as oil and waterto serve as a barrier to chemical degradation for the cannabinoid while on its journey through the body.

Other encapsulation methods can help with potency issues by increasing absorption, they can help decrease side effects, and they can help cover a substances bitter taste.

Specific cannabis strains could even have tailored therapeutic profiles, and cannabinoids could be bioengineered to produce enhanced effects.

Scientists envision a superclass of cannabinoid nanocarriers that have potential to treat a wide array of endocannabinoid insufficiency issues and thus a wide variety of diseases.

In one example, researchers are looking at novel ways to deliver substances across the difficult blood-brain barrier. This barrier is the bodys built-in defense mechanism to protect the brain, so the ability to transport substances across it directly affects a treatments efficacy.

To this end, scientists are engineering lipid nanocapsules decorated with minute cannabinoids like CBD as novel therapies for diseases of the central nervous system.

Nanotechnology has already transformed drug delivery in profound ways, and cannabinoid delivery is part of this exciting future. There are challenges, of course. Cannabinoids quickly degrade in water and are susceptible to other kinds of degradation, and that presents delivery issues.

More recent discoveries, including the decoding of the cannabis genome, discovery of the main CB1R and CB2R receptors within the human endocannabinoid system (ECS), and discovery of other receptors, are also foundational efforts that contribute to cannabinoid nanotechnology.

The latest research shows great progress in the formulation of targeted cannabinoid-nanocarrier delivery systems, and as such may provide key therapies particularly for central nervous system disorders. As scientists continue to make improvements in both bio-efficacy and bioavailability, cannabis nanotechnology represents an exciting and brave new world.

Read the rest here:
How can nanomedicine be applied to cannabis? - Leafly